• market on mobile

Pause Refresh

Latest News and Updates on "received"

  • Filter news by :
  • Lupin gains after US drug regulator nod for generic drug
  • Lupin gains after US drug regulator nod for generic drug
    Mumbai,Feb 06, 09:19

    The stock advanced 1.3 percent after the company received final approval for its Triamcinolone Acetonide Cream USP, from USFDA to market a generic equivalent of Mylan Pharmaceuticals Inc.s Triamcinolone Acetonide Cream....

  • Dishman Pharmaceuticals edges higher
  • Dishman Pharmaceuticals edges higher
    Mumbai,Feb 02, 11:24

    The stock gained 3 percent after the company said that it has received Establishment Inspection Report from the US drug regulator for Bavla facility....

  • Lupin gains after receiving USFDA approval
  • Lupin gains after receiving USFDA approval
    Mumbai,Jan 11, 15:14

    The stock jumped 2.2 percent after the company announced that it has received final approval for its Desoximetasone Cream from the United States Food and Drug Administration....

  • MEP Infra strengthens 3.6%
  • MEP Infra strengthens 3.6%
    Mumbai,Jan 03, 10:26

    The stock jumped after the company received user fee collection rights at Brijghat fee plaza in Uttar Pradesh....

  • Lupin nudges higher
  • Lupin nudges higher
    Mumbai,Jan 02, 13:52

    The stock advanced 0.8 percent after the company announced that it has received final approval for its Cevimeline Hydrochloride Capsules, 30 mg from the US drug regulator....

  • Bombay Dyeing gains
  • Bombay Dyeing gains
    Mumbai,Jan 02, 11:10

    The stock jumped 2.8 percent after the company entered into an agreement for sale of land & building, some specific utility machineries and a company owned flat....

  • Ujaas Energy energizes
  • Ujaas Energy energizes
    Mumbai,Jan 02, 10:24

    The stock jumped 3.15 percent after the company announced that it has received letter of Intent from MOIL for 5 megawatts solar power photovoltaic plant in Maharashtra....

  • Lupin inches up
  • Lupin inches up
    Mumbai,Dec 29, 14:30

    The stock gained 0.6 percent after the company said it has received tentative approval from the US drug regulator to market a generic version of Salix Pharmaceuticals lncs Giazo tablets, 1.1 gm....




INTRADAY CHART

Prev. Close : 29332.16
You need to upgrade your Flash Player
Prev. Close : 9086.3
You need to upgrade your Flash Player



feedback